Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2015–2026 · cooperative agreement · U01
Genomically informed agent selection and testing in osteosarcoma patient-derived xenograft models
Richard G. Gorlick · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2020 · research · R01
Target p70S6K for Chemodietary Prevention/Early Intervention of ER- Breast Cancer
Dihua Yu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2020 · research · R01
Targeting adipocyte-secreted chemerin for chemotherapy resistance in myeloma
Jing Yang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2020 · research · R01
High-throughput sequencing to identify novel melanoma susceptibility genes
Lisa Cannon Albright · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2020 · grant · Standard Grant
Bilateral BBSRC-NSF/BIO: Bayesian Quantitative Proteomics
Jeffrey Morris · The University of Texas MD Anderson Cancer Center · funded by National Science Foundation
2015–2022 · research · R01
Clinical Significance of Pancreatic Cancer Differentiation and Dedifferentiation
Huamin Wang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2021 · research · R01
Negative regulation of C-type lectin receptor signaling in response to fungal infection
Haoqiang Ying · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2020 · cooperative agreement · U01
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2021 · cooperative agreement · U01
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2024 · research · R01
Controlling the core airway mucin secretion machinery to prevent pathophysiology
Burton F Dickey · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2020 · research · R01
Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors
Michelle A T Hildebrandt · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2023 · research · R01
Regulation of chromatin organization and dynamics by INO80
Blaine Bartholomew · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2020 · research · R34
Low Reward Sensitivity and Behavioral Activation Therapy for Smoking Cessation
Jennifer Anne Minnix · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2020 · cooperative agreement · U24
Next-Generation Clustered Heat Maps for fluent, interactive exploration of omic data: Cloud Pilot Supplement
Bradley Mcintosh Broom · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2024 · research · R01
The Metabolic Basis of Cancer-Related Fatigue
Robert Dantzer · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2020 · cooperative agreement · U01
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2020 · cooperative agreement · U01
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
Ziding Feng · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2020 · research · R01
Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors
Michelle A T Hildebrandt · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2021 · cooperative agreement · U01
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2025 · research · R01
Protecting colonic mucus to mitigate acute intestinal graft-versus-host disease
Robert Jenq · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2027 · training · T32
Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology
Gang Bao · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2020 · cooperative agreement · U01
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
Liang Li · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2020 · training · T32
Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology
Sunil Krishnan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2021 · research · R01
Role of TJP1 in Sensitivity and Resistance to Proteasome Inhibitors in Myeloma
Robert Zygmunt Orlowski · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2025 · research · R01
PAF-Remodeled DREAM Complex in Cancer and Regeneration
Jae-Il Park · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2023 · research · R01
Regulation of chromatin organization and dynamics by INO80
Blaine Bartholomew · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2020 · research · R01
Negative regulation of C-type lectin receptor signaling in response to fungal infection
Mien-Chie Hung · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2020 · cooperative agreement · U01
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas
Anirban Maitra · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2025 · research · R01
Protecting colonic mucus to mitigate acute intestinal graft-versus-host disease
Robert Jenq · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2020 · research · R01
Regulation and function of nonlymphoid organ CD103 dendritic cells
Stephanie S Watowich · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2027 · training · T32
Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology
Gang Bao · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2015–2030 · cooperative agreement · U01
Chronic Pancreatitis Clinical Research Consortium (CPCRC) Data Coordinating Center (CPCRC-DCC)
Liang Li · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2014–2020 · research · R01
Discovery of Risk Loci and Genomics of Pancreatic Cancer through Exome Sequencing
Chad Daniel Huff · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2014–2020 · cooperative agreement · UM1
Southwest Early Clinical Trials Consortium
S. Gail Eckhardt · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2014–2020 · research · R01
Molecular mechanisms and epigenetic signatures that specify thymus fate
Nancy R Manley · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2014–2025 · research · R01
Studying metabolic stress signaling in renal cancer
Boyi Gan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2014–2020 · research · R01
The role of the PI3K pathway in immune resistance
Michael Davies · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2014–2020 · cooperative agreement · UM1
Southwest Early Clinical Trials Consortium
S. Gail Eckhardt · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2014–2020 · research · R01
Studying metabolic stress signaling in renal cancer
Boyi Gan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2014–2025 · research · R01
Studying metabolic stress signaling in renal cancer
Boyi Gan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
